← Back to Search

Tilt Table Therapy for Parkinson's Disease with Orthostatic Hypotension

N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of idiopathic Parkinson Disease using the Movement Disorders Society (MDS) Clinical Diagnostic Criteria
Age at least 50 years old
Must not have
Dementia (including PD dementia)
Taking antihypertensive medications or alpha-adrenergic blocking medications, since these can cause hypotension
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how low blood pressure (BP) affects brain function in people with Parkinson's disease (PD), who often experience problems thinking and orthostatic hypotension (OH), i.e., low BP when standing.

Who is the study for?
This trial is for people over 50 with Parkinson's Disease (PD) who can walk without help and speak English fluently. They should be in the early to moderate stages of PD but not have unstable medical conditions, uncontrolled diabetes, recent fainting episodes, severe involuntary movements, significant carotid artery narrowing, hearing or vision impairments not corrected by devices, pregnancy, dementia including PD dementia, a history of stroke or brain surgery.
What is being tested?
The study tests how blood pressure affects thinking and brain blood flow in PD patients when they change positions from lying down to standing up. It uses wearable technology to monitor these changes continuously during cognitive tests performed both while supine and upright.
What are the potential side effects?
There are no direct side effects from the interventions being studied since it involves non-invasive monitoring using a tilt table test. However, participants may experience their usual symptoms related to orthostatic hypotension such as lightheadedness or dizziness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Parkinson's Disease.
Select...
I am at least 50 years old.
Select...
My Parkinson's is early to moderate; I can walk without help.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with dementia.
Select...
I am taking medication for high blood pressure or medications that affect my blood pressure.
Select...
I have fainted in the last week.
Select...
I have diabetes or another disease that is not under control.
Select...
I do not have any current severe or uncontrolled health issues.
Select...
I have had deep brain stimulation surgery.
Select...
I have had a stroke or brain bleed in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Delis-Kaplan Executive Function System Verbal Fluency Test score (number of words per minute). Minimum: 0; Maximum: N/A; higher is better
Oxygenated and deoxygenated hemoglobin change from baseline

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Upright cognitive testing firstExperimental Treatment1 Intervention
The cognitive testing sessions will be alternated between supine and upright positions. This group will perform cognitive testing sessions in the following order: 1) upright, 2) supine, 3) upright, 4) supine.
Group II: Supine cognitive testing firstExperimental Treatment1 Intervention
The cognitive testing sessions will be alternated between supine and upright positions. This group will perform cognitive testing sessions in the following order: 1) supine, 2) upright, 3) supine, 4) upright.

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterOTHER
861 Previous Clinical Trials
12,932,766 Total Patients Enrolled
Drexel UniversityOTHER
156 Previous Clinical Trials
48,212 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,189 Previous Clinical Trials
1,587,681 Total Patients Enrolled

Media Library

Supine cognitive testing first Clinical Trial Eligibility Overview. Trial Name: NCT05400174 — N/A
Parkinson's Disease Research Study Groups: Supine cognitive testing first, Upright cognitive testing first
Parkinson's Disease Clinical Trial 2023: Supine cognitive testing first Highlights & Side Effects. Trial Name: NCT05400174 — N/A
Supine cognitive testing first 2023 Treatment Timeline for Medical Study. Trial Name: NCT05400174 — N/A
~9 spots leftby Jul 2025